Index -
P/E 302.72
EPS (ttm) 0.86
Insider Own 3.45%
Shs Outstand 38.36M
Perf Week -2.36%
Market Cap 10.00B
Forward P/E 68.65
EPS next Y 3.80
Insider Trans -6.82%
Shs Float 37.06M
Perf Month 3.35%
Income 34.55M
PEG 9.07
EPS next Q 0.90
Inst Own 93.36%
Short Float 5.05%
Perf Quarter 12.17%
Sales 1.16B
P/S 8.60
EPS this Y 33.66%
Inst Trans -0.29%
Short Ratio 4.92
Perf Half Y 59.29%
Book/sh 28.78
P/B 9.06
EPS next Y 35.92%
ROA 2.34%
Short Interest 1.87M
Perf Year 0.80%
Cash/sh 7.58
P/C 34.38
EPS next 5Y 33.36%
ROE 3.13%
52W Range 148.00 - 277.89
Perf YTD 9.77%
Dividend Est. -
P/FCF 74.56
EPS past 5Y 66.20%
ROI 2.62%
52W High -6.20%
Beta 0.52
Dividend TTM -
Quick Ratio 3.25
Sales past 5Y 18.51%
Gross Margin 62.19%
52W Low 76.13%
ATR (14) 6.70
Dividend Ex-Date -
Current Ratio 5.82
EPS Y/Y TTM -15.07%
Oper. Margin 6.74%
RSI (14) 50.68
Volatility 1.84% 2.48%
Employees 4200
Debt/Eq 0.21
Sales Y/Y TTM 16.96%
Profit Margin 2.97%
Recom 1.60
Target Price 266.12
Option/Short Yes / Yes
LT Debt/Eq 0.19
EPS Q/Q 220.86%
Payout 0.00%
Rel Volume 0.70
Prev Close 261.50
Sales Surprise 1.24%
EPS Surprise 23.73%
Sales Q/Q 11.11%
Earnings Feb 18 AMC
Avg Volume 380.24K
Price 260.67
SMA20 -1.53%
SMA50 3.31%
SMA200 23.18%
Trades
Volume 266,248
Change -0.32%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-21-25 Initiated
UBS
Buy
$305
Dec-17-24 Initiated
Oppenheimer
Outperform
$275
Dec-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$190 → $275
Sep-18-24 Initiated
Stifel
Buy
$238
Sep-03-24 Initiated
Leerink Partners
Outperform
$263
Jul-31-24 Downgrade
Wells Fargo
Overweight → Equal Weight
$289 → $150
Jul-31-24 Downgrade
Citigroup
Buy → Neutral
$165 → $178
Feb-23-24 Downgrade
JP Morgan
Overweight → Neutral
$284 → $250
Sep-06-23 Initiated
Morgan Stanley
Equal-Weight
$265
Jul-19-23 Initiated
Robert W. Baird
Outperform
$375
Mar-29-23 Downgrade
Needham
Buy → Hold
Jan-30-23 Initiated
Piper Sandler
Overweight
$275
Nov-04-22 Upgrade
Citigroup
Neutral → Buy
$217 → $212
Oct-12-22 Initiated
Jefferies
Buy
$230
Oct-05-22 Downgrade
Citigroup
Buy → Neutral
$170 → $217
Sep-09-22 Upgrade
Needham
Hold → Buy
Jul-18-22 Initiated
RBC Capital Mkts
Outperform
$195
Apr-19-22 Initiated
Deutsche Bank
Buy
$250
Mar-08-22 Initiated
Needham
Hold
Sep-16-21 Initiated
Truist
Buy
$350
Show Previous Ratings
Jan-21-25 04:30PM
Jan-16-25 12:45PM
Jan-08-25 05:06AM
Dec-30-24 04:30PM
Dec-25-24 12:45PM
09:45AM
Loading…
Dec-23-24 09:45AM
Dec-19-24 07:37AM
Dec-09-24 12:45PM
Dec-06-24 09:45AM
Nov-29-24 11:31AM
Nov-25-24 05:05PM
Nov-21-24 12:45PM
Nov-20-24 04:30PM
Nov-18-24 10:00AM
Nov-17-24 04:50PM
12:29PM
Loading…
Nov-06-24 12:29PM
Nov-05-24 12:45PM
09:50AM
09:00AM
Nov-04-24 11:19AM
Oct-31-24 03:15AM
Oct-30-24 06:30PM
05:30PM
04:24PM
(Associated Press Finance)
04:05PM
Oct-23-24 10:02AM
Oct-15-24 10:31AM
Oct-14-24 06:20PM
09:00AM
Oct-10-24 09:00AM
07:50AM
Loading…
Oct-09-24 07:50AM
Oct-02-24 04:30PM
Sep-18-24 06:29PM
Sep-16-24 06:53AM
03:00AM
Sep-06-24 01:49AM
01:49AM
Aug-29-24 11:31AM
06:55AM
Aug-27-24 04:30PM
Aug-21-24 04:30PM
08:03AM
Aug-16-24 01:01AM
Aug-13-24 07:00AM
Aug-02-24 04:30PM
Jul-31-24 01:50PM
(Thomson Reuters StreetEvents)
10:03AM
Jul-30-24 08:56PM
07:00PM
05:30PM
04:32PM
(Associated Press Finance)
04:05PM
Jul-23-24 10:01AM
Jul-18-24 04:39AM
Jul-17-24 12:45PM
Jul-04-24 03:30AM
Jul-02-24 04:05PM
Jun-13-24 09:45AM
Jun-06-24 11:31AM
Jun-04-24 04:30PM
May-23-24 04:30PM
May-16-24 03:22AM
May-15-24 07:41AM
May-13-24 12:08PM
May-08-24 01:42PM
10:43AM
May-07-24 05:35PM
04:42PM
(Associated Press Finance)
04:05PM
May-01-24 04:05PM
Apr-24-24 11:43AM
Apr-23-24 09:45AM
09:00AM
Apr-09-24 04:05PM
Apr-08-24 09:35AM
Apr-04-24 01:55AM
Mar-05-24 09:49AM
Feb-27-24 09:45AM
Feb-26-24 11:42AM
Feb-23-24 11:40AM
(Thomson Reuters StreetEvents) -9.25%
10:44AM
12:11AM
Feb-22-24 05:40PM
04:35PM
04:35PM
(Associated Press Finance)
04:05PM
Feb-20-24 07:12AM
Feb-18-24 01:26PM
Feb-15-24 10:00AM
Feb-01-24 04:05PM
Jan-18-24 11:39AM
Dec-22-23 09:37AM
Dec-21-23 07:01AM
Dec-19-23 10:30AM
Dec-18-23 07:50PM
Nov-30-23 09:55AM
07:37AM
Nov-28-23 09:54AM
09:00AM
Nov-17-23 01:03PM
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Grewal Harpreet Director Jan 03 '25 Sale 241.28 167 40,294 8,530 Jan 06 08:03 PM Kassing Don W. Director Jan 02 '25 Sale 238.84 170 40,603 665 Jan 06 08:03 PM Grewal Harpreet Director Jan 03 '25 Proposed Sale 241.28 167 40,294 Jan 03 03:50 PM Roberts Johanna EVP, Gen. Counsel & Secretary Dec 26 '24 Option Exercise 22.04 1,350 29,754 64,000 Dec 27 08:02 PM Elsesser Adam CEO and President Dec 20 '24 Sale 242.96 15,000 3,644,438 837,582 Dec 23 07:37 PM Roberts Johanna EVP, Gen. Counsel & Secretary Dec 02 '24 Sale 244.49 600 146,697 63,444 Dec 03 08:27 PM Shiu Lambert Chief Accounting Officer Dec 03 '24 Option Exercise 12.36 5,250 64,890 25,278 Dec 03 08:27 PM Shiu Lambert Chief Accounting Officer Nov 29 '24 Sale 242.56 1,798 436,123 20,682 Dec 03 08:27 PM Shiu Lambert Chief Accounting Officer Dec 02 '24 Sale 243.01 654 158,929 20,028 Dec 03 08:27 PM LAMBERT SHIU Officer Dec 02 '24 Proposed Sale 243.01 654 158,929 Dec 02 04:05 PM LAMBERT SHIU Officer Nov 29 '24 Proposed Sale 242.56 1,798 436,123 Nov 29 01:28 PM Elsesser Adam CEO and President Nov 20 '24 Sale 237.28 15,000 3,559,176 852,582 Nov 22 08:38 PM Adam Elsesser Affiliate Nov 20 '24 Proposed Sale 237.11 30,000 7,113,300 Nov 20 05:42 PM Roberts Johanna EVP, Gen. Counsel & Secretary Nov 18 '24 Sale 239.74 600 143,843 64,044 Nov 19 08:04 PM Elsesser Adam CEO and President Oct 21 '24 Sale 204.56 15,000 3,068,367 867,582 Oct 23 07:31 PM Grewal Harpreet Director Oct 02 '24 Sale 190.83 166 31,678 8,697 Oct 03 07:33 PM Roberts Johanna EVP, Gen. Counsel & Secretary Oct 01 '24 Sale 190.76 600 114,456 60,488 Oct 03 07:32 PM Kassing Don W. Director Oct 01 '24 Sale 193.93 170 32,968 835 Oct 03 07:32 PM Grewal Harpreet Director Oct 02 '24 Proposed Sale 190.83 166 31,678 Oct 02 04:00 PM Elsesser Adam CEO and President Sep 20 '24 Sale 197.71 15,000 2,965,646 882,582 Sep 24 07:29 PM Roberts Johanna EVP, Gen. Counsel & Secretary Sep 03 '24 Sale 206.22 600 123,733 61,088 Sep 05 07:48 PM Grewal Harpreet Director Sep 04 '24 Sale 204.11 782 159,614 8,863 Sep 05 07:48 PM Grewal Harpreet Director Sep 04 '24 Proposed Sale 204.11 782 159,614 Sep 04 04:13 PM Johanna Roberts Officer Sep 03 '24 Proposed Sale 202.32 2,400 485,568 Sep 03 07:02 PM Elsesser Adam CEO and President Aug 23 '24 Sale 203.37 28,380 5,771,597 897,582 Aug 26 07:46 PM Elsesser Adam CEO and President Aug 22 '24 Sale 200.00 1,620 324,000 925,962 Aug 26 07:46 PM Adam Elsesser Affiliate Aug 22 '24 Proposed Sale 195.21 60,000 11,712,600 Aug 22 04:49 PM Roberts Johanna EVP, Gen. Counsel & Secretary Aug 13 '24 Sale 175.98 600 105,587 61,688 Aug 15 07:41 PM Elsesser Adam CEO and President Jul 17 '24 Sale 202.52 15,000 3,037,744 927,582 Jul 19 07:31 PM Kassing Don W. Director Jul 01 '24 Sale 179.99 170 30,598 1,005 Jul 03 08:02 PM Roberts Johanna EVP, Gen. Counsel & Secretary Jul 01 '24 Sale 179.20 600 107,519 62,288 Jul 03 08:01 PM Roberts Johanna EVP, Gen. Counsel & Secretary Jun 03 '24 Sale 188.90 600 113,339 62,888 Jun 05 07:31 PM Elsesser Adam CEO and President May 20 '24 Sale 200.98 15,000 3,014,734 942,582 May 22 07:38 PM Roberts Johanna EVP, Gen. Counsel & Secretary May 13 '24 Sale 207.41 600 124,447 63,488 May 15 07:34 PM Roberts Johanna EVP, Gen. Counsel & Secretary Apr 01 '24 Sale 217.07 600 130,242 64,281 Apr 03 07:42 PM Kassing Don W. Director Apr 01 '24 Sale 223.18 170 37,941 1,175 Apr 03 07:42 PM Elsesser Adam CEO and President Mar 06 '24 Option Exercise 7.75 5,000 38,750 5,000 Mar 08 08:10 PM Kassing Don W. Director Mar 01 '24 Sale 234.72 778 182,612 1,345 Mar 05 07:46 PM Roberts Johanna EVP, Gen. Counsel & Secretary Mar 01 '24 Sale 237.68 600 142,607 62,997 Mar 05 07:45 PM Bose Arani Director Mar 04 '24 Sale 250.20 7,500 1,876,500 164,294 Mar 05 07:44 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite